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Pilot study investigating the epidemiology of oral Human Papilloma Viral 
infection in young adults. 
Head and neck squamous cell carcinomas (HNSCC) are the sixth most common type of 
cancer worldwide, with around 9,000 HNSCC diagnosed within the UK/annum1. Though 
around 60-75% of HSNCC are linked to smoking and/or alcohol there is a subset of HNSCC 
due to oral infection with the Human Papilloma Virus (HPV)2.  
HPV is the causative agent of cervical cancer 3 and oral HPV infection has shown the same 
risk of developing an oral cancer as a genital HPV associated cancer4. Patients presenting 
at Head and Neck clinics with a HPV-associated HNSCC, particularly in white males under 
the age of 40, are steadily increasing 5 and this increase is not fully understood but has been 
linked to changing life style choices, such as having more oral sex at an earlier age, thereby 
increasing oral HPV infection 6.  
As yet the frequency of oral HPV infection in healthy individuals is not fully determined2, 
partly due to insufficient reproducible oral HPV screening methodologies and the majority of 
the research being focused on HPV HNSCC. Furthermore the impact of the HPV vaccination 
programme on the rates of oral HPV infection has not been investigated. But as females in 
the UK, who were vaccinated from 2009 onwards become sexually active, these 
epidemiological studies can now be conducted.   
Therefore, this pilot study aimed to implement a reproducible oral screening method to 
investigate the epidemiology of oral HPV infection in 18-25 years old, who are a high risk 
group for genital HPV infection, to investigate frequency of infection and to see if any life 
style choice(s), including HPV vaccination, influenced risk of HPV infection.  
Students from a UK university, were asked to complete a questionnaire focused on their life 
styles. These included drinking and smoking habits, relationship status, sexual orientation, if 
they performed open mouth kissing and number of sexual partners. Sexually active students 
also supplied details on their sexual activities (oral, vaginal and anal sex, foreplay and 
masturbation), frequency of condom use, participation in casual sex, when they last changed 
their sexual partner and if ever diagnosed with a STI(s). Females were also asked if/when 
they had received the HPV vaccination. Written consent was obtained before enrolment onto 
the study.  
Participant’s also supplied a mouth swab of buccal cells, which was linked to the 
participant’s questionnaire by a unique identification number. Mucosal DNA was extracted 
from the buccal cells (DNeasy (Qiagen) extraction kit) and DNA viability determined by PCR 
(polymerase chain reaction) to detect cytochrome B and -globulin, mitochondrial and 
chromosomal DNA markers respectively. Viable DNA was then screened by PCR for the 
detection of the HPV L1 protein, which is highly conserved between different HPV strains. A 
HPV positive cervical cell line and HPV negative cervical cell line were used as controls 
(kind gifts by Dr S Roberts, University of Birmingham). Any participants that reproducibly 
showed HPV L1 detection three times were deemed to have an oral HPV infection.  
A total of 124 participants were involved in the study, with 92% being 18-25 years old and 
the gender divide was 67 males to 57 females, with 86 % White British (data not shown). 
Most of the cohort drank alcohol at least once a week and around a fifth smoked (Table 
One). 83% of participants were sexually active and most (91% men, 81% women) were 
heterosexual (data not shown). The most common number of sexual partners were less than 
5, with men overall having more sexual partners than women (Table One). The distribution 
of sexual activities were similar across both genders (Table One), apart from masturbation in 
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which 80% of men masturbated compared to 38% women. Condom use was similar 
between genders, as was the number of men or women that had one-night stands (Table 
One).  70% of females (40 out of 57) had received the HPV vaccination.   
Laboratory screening of the mouth samples identified that 4% of the total cohort had a 
detectable oral HPV infection and all infected individuals, 2 females and 3 males, were aged 
between18 and 21. This pilot data supports previous oral HPV epidemiological studies within 
the United States, who demonstrated oral infectivity rates of between 2.5% and 5.4% in 18-
24 year olds 5,6,7,.  
When comparing what life style choices the HPV infected individuals were undertaking in 
relation to the rest of the cohort (Table One), the majority of infected individuals smoked with 
2 out of 3 oral HPV infected males smoking and both infected females. This gave an oral 
HPV prevalence of infection of 16% of men and 18% of women who smoked, who also had 
an oral HPV infection (Table One). This study’s finding that the majority (80%) of orally HPV 
infected individuals also smoked, correlates with research conducted in the US who found 
that smoking was a risk factor for contracting an oral HPV infection5. Why smoking may 
increase the risk of contracting oral HPV is not yet determined, but could be due to the 
damaging effects smoking has on the mouth epithelial layer thereby allowing HPV entry 
and/or inducing immunosuppression within smokers allowing a more abundant HPV infection 
9. Therefore this pilot study highlights that further investigation needs to be undertaken to 
examine the impact of smoking on contracting oral HPV, and also how this correlates to 
development of HPV HNSCC. 
Examination of how the sexual behaviour of the cohort impacted on oral HPV infection 
showed that all infected individuals were; sexually active, not in a monogamous relationship 
(data not shown) and had undertaken more risky sexual behaviour such as; one-night 
stands, having more than 5 sexual partners and/or not always using a condom (Table One).  
A noteworthy finding of this pilot study is though participants are using condoms, they are 
not being used that frequently (Table One) and only being used for penetrative sex (data not 
shown) so thereby not offering oral HPV protection. This inconsistent use of condoms when 
engaging in sexual activities correlates with other research from this research group on oral 
STI’s and how to prevent them (Lees et al., unpublished data) and highlights the requirement 
for better education about the risk of oral STIs, particularly in relation to HPV and the 
potential development of HSNCC.  
The observation within this study that undertaking more high risk sexual activities appears to 
lead to increased prevalence of oral HPV infection (Table One) corresponds with previous 
genital HPV epidemiology studies. It also supports the observations of oral epidemiological 
HPV studies within the US that sexual behaviour appears to spread oral HPV5, 7, 8 with a 
correlation between the number of sexual partners and increased frequency of HPV 
infection6.   
An unexpected finding of this study was that one of the women infected with oral HPV had 
received vaccination against the high risk strains HPV 16 and HPV 18, as part of the UK 
HPV vaccination programme (Table One), the other infected woman had not been 
vaccinated. It is possible that the vaccinated woman may have contracted HPV before she 
was vaccinated, as she was part of the UK catch up programme which vaccinated girls 
between 16-18 years old and may have already been sexually active, or she may have a 
strain that is not prevented by HPV vaccination. It should be noted that 70% of the female 
cohort said they were vaccinated against HPV and only one woman of this cohort was 
positive for HPV.  This resulted in only 2.5% of the cohort of HPV vaccinated females having 
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oral HPV (Table One), compared to 5.8% oral HPV prevalence within non-vaccinated 
females (data not shown).  
This pilot study is one of the first studies conducted within the UK establishing a reproducible 
oral HPV screening method, to look to quantify the rates of oral HPV infection. Though the 
number of infected individuals are small the epidemiological findings of oral HPV infection 
within this UK cohort reflect previous studies conducted within the US, indicating that oral 
HPV is mainly being spread by sexual practices but smoking can also influence oral HPV 
infection. This pilot study indicates that more men than women appear to be contracting an 
oral HPV infection, again confirming previous US studies, and correlates with the fact that a 
higher frequency of men are developing a HPV HNSCC 2. However why more men are 
contracting oral HPV infections is something yet to be determined and will require further 
research. Furthermore, the ability of the HPV vaccination to prevent oral HPV infection is a 
key public health agenda that needs future research, particular in relation to the proposed 
impact of herd immunity upon males within the UK, who do not receive the HPV vaccination. 
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Life style choice Total number 
of males 
(number of 
HPV infected 
males) 
Oral HPV 
prevalence 
in males  
Total number of 
females 
(number of HPV 
infected 
females) 
Oral HPV 
prevalence in 
females 
Consumes Alcohol 62 (3) 4.8 % 54 (2) 3.7% 
Smokes 12 (2) 16.6% 11 (2) 18.2% 
Open mouth kisses 58 (3) 5.1% 52 (2) 3.8% 
<5 sexual partners 25 (1) 4% 25 (0) 0% 
5-10 sexual partners 9 (0) 0% 15 (1) 6.7% 
11-20 sexual 
partners 
15 (2) 13.3% 3 (1) 33.3% 
21-40 sexual 
partners 
5 (0) 0% 5 (0) 0% 
Never had one-night 
stand 
20 (0) 0% 22 (0) 0% 
Infrequent one-night 
stands 
13 (2) 15.3% 11 (1) 9% 
Frequent one-night 
stands 
8 (1) 12.5% 7 (0) 0% 
Previous one-night 
stands (over 6 
months ago) 
16 (0) 0% 8 (1) 12.5% 
Always use condom 11 (0) 0% 9 (0) 0% 
Mostly use condom 14 (2) 14.3% 10 (1) 10% 
Sometimes use 
condom 
10 (1) 10% 8 (1) 12.5% 
Never use  condom 21 (0) 0% 20 (0) 0% 
Has vaginal sex 56 (3) 5.3% 47 (2) 4.2% 
Has oral sex 54 (3) 5.5% 46 (2) 4.3% 
Has anal sex 15 (0) 0% 12 (0) 0% 
Preforms foreplay 54 (3) 5.5% 40 (2) 5% 
Masturbates  54 (3) 5.5% 22 (1) 4.5% 
Diagnosed with STI 6 (0) 0% 1 (0) 0% 
Received HPV 
vaccination 
N/A N/A 40 (1) 2.5% 
 
Table One: The number of study participants undertaking identified risks for contracting genital and 
oral HPV infection. The data is divided into males and females, and show the number of participants 
for each gender that answered yes to undertaking that particular life style choice when completing the 
questionnaire (column 2 and 4). In brackets is the number of HPV infected individuals, from the same 
cohort, that undertook the same life style choice. In columns 3 and 5 the percentage prevalence of 
oral HPV infection within the male or female cohort is calculated. This percentage prevalence of oral 
HPV infection was derived by dividing the number of infected individuals, males or females, by the 
total number of respective males or females in the study who performed the same life style choice.  N 
=124, 67 males: 57 females 
 
Table(s)
Highlights of: Pilot study investigating the epidemiology of oral Human Papilloma Viral 
infection in young adults. 
 
 UK based study investigating the rates of oral HPV infection in young adults  
 An oral HPV infectivity rate of 4% was found within the cohort  
 Particular life style choices, such as sexual behaviour and smoking, appeared to 
influence the rates of HPV infection  
 
*Highlights (for review)
